4/14
08:17 am
rlay
Relay Therapeutics (RLAY) is now covered by JonesTrading. They set a "hold" rating and a $18.00 price target on the stock.
Medium
Report
Relay Therapeutics (RLAY) is now covered by JonesTrading. They set a "hold" rating and a $18.00 price target on the stock.
4/10
06:16 am
rlay
Relay Therapeutics (RLAY) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
Low
Report
Relay Therapeutics (RLAY) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
4/8
12:48 pm
rlay
Relay Therapeutics (RLAY) had its price target raised by Barclays PLC from $17.00 to $21.00. They now have an "overweight" rating on the stock.
Low
Report
Relay Therapeutics (RLAY) had its price target raised by Barclays PLC from $17.00 to $21.00. They now have an "overweight" rating on the stock.
4/6
01:38 pm
rlay
Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains? [Yahoo! Finance]
Neutral
Report
Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains? [Yahoo! Finance]
4/4
09:52 pm
rlay
Relay Therapeutics (RLAY) Is Up 30.6% After Expanding Zovegalisib Into Vascular Anomalies Data Reveal [Yahoo! Finance]
Low
Report
Relay Therapeutics (RLAY) Is Up 30.6% After Expanding Zovegalisib Into Vascular Anomalies Data Reveal [Yahoo! Finance]
4/3
03:01 am
rlay
Relay Therapeutics (RLAY) Climbs 16% Ahead of Cancer Treatment Update [Yahoo! Finance]
Low
Report
Relay Therapeutics (RLAY) Climbs 16% Ahead of Cancer Treatment Update [Yahoo! Finance]
4/2
04:56 pm
rlay
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026 [Yahoo! Finance]
Low
Report
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026 [Yahoo! Finance]
4/2
04:05 pm
rlay
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
Low
Report
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
3/23
08:04 am
rlay
Relay Therapeutics (RLAY) had its price target raised by HC Wainwright from $14.00 to $19.00. They now have a "buy" rating on the stock.
Medium
Report
Relay Therapeutics (RLAY) had its price target raised by HC Wainwright from $14.00 to $19.00. They now have a "buy" rating on the stock.
3/19
03:28 pm
rlay
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. [Yahoo! Finance]
Neutral
Report
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. [Yahoo! Finance]
3/17
09:46 am
rlay
Relay Therapeutics (RLAY) had its price target raised by Citizens Jmp from $15.00 to $17.00. They now have a "market outperform" rating on the stock.
Low
Report
Relay Therapeutics (RLAY) had its price target raised by Citizens Jmp from $15.00 to $17.00. They now have a "market outperform" rating on the stock.
3/17
09:19 am
rlay
Relay Therapeutics (RLAY) had its price target raised by Wells Fargo & Company from $15.00 to $17.00. They now have an "overweight" rating on the stock.
Low
Report
Relay Therapeutics (RLAY) had its price target raised by Wells Fargo & Company from $15.00 to $17.00. They now have an "overweight" rating on the stock.
3/16
09:04 pm
rlay
Relay Therapeutics (RLAY) had its "outperform" rating reaffirmed by Oppenheimer Holdings, Inc..
Low
Report
Relay Therapeutics (RLAY) had its "outperform" rating reaffirmed by Oppenheimer Holdings, Inc..
3/16
07:00 am
rlay
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
Medium
Report
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
3/11
12:48 pm
rlay
Relay Therapeutics, Inc. (RLAY) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Relay Therapeutics, Inc. (RLAY) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/6
03:51 pm
rlay
Relay Therapeutics, Inc. (RLAY) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Neutral
Report
Relay Therapeutics, Inc. (RLAY) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
2/28
07:02 pm
rlay
Relay Therapeutics (RLAY) Valuation After Breakthrough Therapy Win And Narrower Loss Attracts Fresh Investor Interest [Yahoo! Finance]
Medium
Report
Relay Therapeutics (RLAY) Valuation After Breakthrough Therapy Win And Narrower Loss Attracts Fresh Investor Interest [Yahoo! Finance]
2/27
01:11 pm
rlay
Relay Therapeutics (RLAY) had its price target raised by Wells Fargo & Company from $13.00 to $15.00. They now have an "overweight" rating on the stock.
Medium
Report
Relay Therapeutics (RLAY) had its price target raised by Wells Fargo & Company from $13.00 to $15.00. They now have an "overweight" rating on the stock.
2/26
04:22 pm
rlay
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones [Yahoo! Finance]
High
Report
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones [Yahoo! Finance]
2/26
04:05 pm
rlay
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
High
Report
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
2/23
04:37 pm
rlay
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March [Yahoo! Finance]
Low
Report
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March [Yahoo! Finance]
2/23
04:05 pm
rlay
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
Low
Report
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
2/19
06:30 pm
rlay
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026 [Yahoo! Finance]
Low
Report
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026 [Yahoo! Finance]
2/19
05:55 pm
rlay
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026
Low
Report
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026
2/7
04:11 pm
rlay
Assessing Relay Therapeutics (RLAY) Valuation After FDA Breakthrough Therapy Designation For Zovegalisib [Yahoo! Finance]
Low
Report
Assessing Relay Therapeutics (RLAY) Valuation After FDA Breakthrough Therapy Designation For Zovegalisib [Yahoo! Finance]